These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26204501)

  • 41. Delivery of plasmid DNA to glial cells using pH-sensitive immunoliposomes.
    Holmberg EG; Reuer QR; Geisert EE; Owens JL
    Biochem Biophys Res Commun; 1994 Jun; 201(2):888-93. PubMed ID: 8003028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes.
    Shi N; Boado RJ; Pardridge WM
    Pharm Res; 2001 Aug; 18(8):1091-5. PubMed ID: 11587478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of four different peptides to enhance accumulation of liposomes into the brain.
    Qin Y; Zhang Q; Chen H; Yuan W; Kuai R; Xie F; Zhang L; Wang X; Zhang Z; Liu J; He Q
    J Drug Target; 2012 Apr; 20(3):235-45. PubMed ID: 22188312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
    Kang YS; Pardridge WM
    J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uptake of cationzied albumin coupled liposomes by cultured porcine brain microvessel endothelial cells and intact brain capillaries.
    Thöle M; Nobmann S; Huwyler J; Bartmann A; Fricker G
    J Drug Target; 2002 Jun; 10(4):337-44. PubMed ID: 12164382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel anti-VEGF165 monoclonal antibody-conjugated liposomal nanocarrier system: physical characterization and cellular uptake evaluation in vitro and in vivo.
    Shi C; Gao F; Gao X; Liu Y
    Biomed Pharmacother; 2015 Feb; 69():191-200. PubMed ID: 25661357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
    Ohta S; Igarashi S; Honda A; Sato S; Hanai N
    Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. By-passing of P-glycoprotein using immunoliposomes.
    Huwyler J; Cerletti A; Fricker G; Eberle AN; Drewe J
    J Drug Target; 2002 Feb; 10(1):73-9. PubMed ID: 11996089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody-targeted immunoliposomes for cancer treatment.
    Gao J; Chen H; Song H; Su X; Niu F; Li W; Li B; Dai J; Wang H; Guo Y
    Mini Rev Med Chem; 2013 Dec; 13(14):2026-35. PubMed ID: 24251805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoliposomes for Targeted Delivery of an Antifibrotic Drug.
    Schuster L; Seifert O; Vollmer S; Kontermann RE; Schlosshauer B; Hartmann H
    Mol Pharm; 2015 Sep; 12(9):3146-57. PubMed ID: 26181293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
    Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells.
    Koning GA; Gorter A; Scherphof GL; Kamps JA
    Br J Cancer; 1999 Aug; 80(11):1718-25. PubMed ID: 10468287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo.
    Maussang D; Rip J; van Kregten J; van den Heuvel A; van der Pol S; van der Boom B; Reijerkerk A; Chen L; de Boer M; Gaillard P; de Vries H
    Drug Discov Today Technol; 2016 Jun; 20():59-69. PubMed ID: 27986226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Preparation of brain targeted immunoliposomes].
    Zhao H; Wang RZ; Wang F; Zhang YH; Chen XW; Li XR; Liu Y; Li GL; Wei JJ; Feng M; Kong YG; Li SF
    Yao Xue Xue Bao; 2009 Nov; 44(11):1285-90. PubMed ID: 21355328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The targeting of immunoliposomes to tumour cells (A431) and the effects of encapsulated methotrexate.
    Jones MN; Hudson MJ
    Biochim Biophys Acta; 1993 Nov; 1152(2):231-42. PubMed ID: 8218324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delivery of beta-galactosidase to mouse brain via the blood-brain barrier transferrin receptor.
    Zhang Y; Pardridge WM
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1075-81. PubMed ID: 15718287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and characterization of immunoliposomes for targeting of antiviral agents.
    Kalvakolanu DV; Abraham A
    Biotechniques; 1991 Aug; 11(2):218-22, 224-5. PubMed ID: 1931020
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
    Hua S; Cabot PJ
    Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice.
    Nässander UK; Steerenberg PA; Poppe H; Storm G; Poels LG; De Jong WH; Crommelin DJ
    Cancer Res; 1992 Feb; 52(3):646-53. PubMed ID: 1732053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Active targeting of brain tumors using nanocarriers.
    Béduneau A; Saulnier P; Benoit JP
    Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.